Microtubule-associated protein MAP2 expression in olfactory bulb in schizophrenia

Psychiatry Research

Volumn 128, Issue 1, 2004, Pages 1-7

  Rioux, Lise ^a,b   Ruscheinsky, Delta ^a   Arnold, Steven Edward ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

AP18; Dendrite; Glomerulus; Plasticity

Indexed keywords

ANTIBODY; EPITOPE; MICROTUBULE ASSOCIATED PROTEIN 2;

ADULT; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITE; HIPPOCAMPUS; HUMAN; IMMUNOCYTOCHEMISTRY; INNERVATION; MICROTUBULE; NERVE CELL DIFFERENTIATION; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCHIZOPHRENIA; SYNAPSE;

AGED; AGED, 80 AND OVER; ANTIBODIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEURONAL PLASTICITY; OLFACTORY BULB; PHOSPHORYLATION; PROSPECTIVE STUDIES; SCHIZOPHRENIA;

EID: 4644236383     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2004.05.022     Document Type: Article

References (34)

1. Arnold S.E. Cellular and molecular neuropathology of the parahippocampal region in schizophrenia. Annals of the New York Academy of Sciences. 911:2000;293-304
2. Arnold S.E., Rioux L. Challenges, status and opportunities for studying developmental neuropathology in adult schizophrenia. Schizophrenia Bulletin. 27:2001;395-416
3. Arnold S.E., Lee V.M., Gur R.E., Trojanowski J.Q. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 88:1991;10850-10854
4. Arnold S.E., Gur R.E., Shapiro R.M., Fisher K.R., Moberg P.J., Gibney M.R., Gur R.C., Blackwell P., Trojanowski J.Q. Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients. American Journal of Psychiatry. 152:1995;731-737
5. Arnold S.E., Han L.-Y., Moberg P.J., Turetsky B.I., Gur R.E., Trojanowski J.Q., Hahn C.-G. Dysregulation of olfactory receptor neuron lineage in schizophrenia. Archives of General Psychiatry. 58:2001;829-835
6. Audesirk G., Cabell L., Kern M. Modulation of neurite branching by protein phosphorylation in cultured rat hippocampal neurons. Developmental Brain Research. 102:1997;247-260
7. Cáceres A., Busciglio J., Ferreira A., Steward O. An immunocytochemical and biochemical study of the microtubule-associated protein MAP-2 during post-lesion dendritic remodeling in the central nervous system of adult rats. Molecular Brain Research. 3:1988;233-246
8. Cotter D., Kerwin R., Doshi B., Martin C.S., Everall L.P. Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia. Brain Research. 765:1997;238-246
9. Cotter D., Wilson S., Roberts E., Kerwin R., Everall I.P. Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophrenia Research. 41:2000;313-323
10. Farbman A.I. Cell Biology of Olfaction. 1992;Cambridge University, New York
11. Hirokawa N., Hisanaga S.I., Shiomura Y. MAP2 is a component of cross-bridges between microtubules and neurofilaments in the neuronal cytoskeleton: quick freeze, deep etch immunoelectron microscopy and reconstitution studies. Journal of Neuroscience. 8:1988;2769-2779
12. Jones L.B., Johnson N., Byne W. Alterations in MAP2 immunocytochemistry in areas 9 and 32 of schizophrenic prefrontal cortex. Psychiatry Research: Neuroimaging. 114:2002;137-148
13. Kratskin I.L. Functional anatomy, central connections, and neurochemistry of the mammalian olfactory bulb. Doty R.L. Handbook of Olfaction and Gustation. 1997;103-126 Marcel Decker, New York
14. Lidow M.S., Song Z.-M., Castner S.A., Allen P.B., Greengard P., Goldman-Rakic P.S. Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex. Biological Psychiatry. 49:2001;1-12
15. Matsutani S., Yamamoto N. Differentiation of mitral cell dendrites in the developing main olfactory bulbs of normal and naris-occluded rats. Journal of Comparative Neurology. 418:2000;402-410
16. Matus A. Microtubule-associated proteins: their potential role in determining neuronal morphology. Annual Review of Neuroscience. 11:1988;29-44
17. Moberg P.J., Agrin R., Gur R.E., Gur R.C., Turetsky B.I., Doty R.L. Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology. 21:1999;325-340
18. Moore J.K., Guan Y.L., Shi S.R. MAP2 expression in developing dendrites of human brainstem auditory neurons. Journal of Chemical Neuroanatomy. 16(1):1998;1-15
19. Mukaetova-Ladinska E.B., Hurt J., Honer W.G., Harrington C.R., Wischik C.M. Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics. Neuroscience Letters. 317:2002;161-165
20. Nissanov J., McEachron D.L. Advances in image processing for autoradiography. Journal of Chemistry & Neuroanatomy. 4:1991;329-342
21. Philpot B.D., Lim J.H., Halpain S. Experience-dependent modifications in MAP2 phosphorylation in rat olfactory bulb. Journal of Neuroscience. 24:1997;9596-9604
22. Quinlan E.M., Halpain S. Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors. Neuron. 16:1996;357-368
23. Riederer B.M., Innocenti G.M. MAP2 isoforms in developing cat cerebral cortex and corpus callosum. European Journal of Neuroscience. 4:1992;1376-1386
24. Riederer B.M., Draberova E., Viklicky V., Draber P. Changes of MAP2 phosphorylation during brain development. Journal of Histochemistry and Cytochemistry. 43:1995;1269-1284
25. Rieux C., Carney R., Lupi D., Dkhissi-Benyahya O., Jansen K., Chounlamountri N., Foster R.G., Cooper H.M. Analysis of immunohistochemical label of Fos protein in the suprachiasmatic nucleus: comparison of different methods of quantification. Journal of Biological Rhythms. 17(2):2002;121-136
26. Rioux L., Kazi H.A., Arnold S.E. Abstracts-Society for Neuroscience. 32:2002;. Program no. 706.2
27. Rosoklija G., Toomayan G., Ellis S.P., Keilp J.G., Mann J.J., Latov N., Hays A.P., Dwork A.J. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Archives of General Psychiatry. 57(4):2000;349-356
28. Schwab C, Bondada V., Sparks D.L., Cahan L.D., Geddes J.W. Postmortem changes in the levels and localization of microtubule-associated proteins (tau, MAP2 and MAP1B) in the rat and human hippocampus. Hippocampus. 4(2):1994;210-225
29. Shipley M.T., Ennis M. Functional organization of olfactory system. Journal of Neurobiology. 30(1):1996;123-176
30. Svensson M., Aldskogius H. The effect of axon injury on microtubule-associated protein MAP2, 3 and 5 in the hypoglossal nucleus of the adult rat. Journal of Neurocytology. 21:1992;222-231
31. Svensson M., Aldskogius H. The effect of axon injury on microtubule-associated protein MAP2 mRNA in the hypoglossal nucleus of the adult rat. Brain Research. 581:1992;319-322
32. Turetsky B.I., Moberg P.J., Yousem D.M., Doty R.L., Arnold S.E., Gur R.E. Reduced olfactory bulb volume in patients with schizophrenia. American Journal of Psychiatry. 157:2000;828-830
33. Verhaagen J., Ostreicher A.B., Gispen W.H., Margolis F.L. The expression of the growth associated protein B50/GAP43 in the olfactory system of neonatal and adult rats. Journal of Neuroscience. 9:1989;683-691
34. Walaas S.J., Nairn A.C. Multisite phosphorylation of microtubule- associated protein 2 (MAP2) in rat brain: peptide mapping distinguishes between cyclic AMP-, calcium/calmodulin-, and calcium/phospholipid-regulated phosphorylation mechanisms. Journal of Molecular Neuroscience. 1:1989;117-127